Cytoadherence and virulence - the case of Plasmodium knowlesi malaria. by Fatih, Farrah A et al.
RESEARCH Open Access
Cytoadherence and virulence - the case of
Plasmodium knowlesi malaria
Farrah A Fatih1, Angela Siner2, Atique Ahmed2, Lu Chan Woon3, Alister G Craig4, Balbir Singh2, Sanjeev Krishna1,2
and Janet Cox-Singh1,2*
Abstract
Background: Cytoadherence of infected red blood cells to brain endothelium is causally implicated in malarial coma,
one of the severe manifestations of falciparum malaria. Cytoadherence is mediated by specific binding of variant
parasite antigens, expressed on the surface of infected erythrocytes, to endothelial receptors including, ICAM-1, VCAM
and CD36. In fatal cases of severe falciparum malaria with coma, blood vessels in the brain are characteristically
congested with infected erythrocytes. Brain sections from a fatal case of knowlesi malaria, but without coma, were
similarly congested with infected erythrocytes. The objective of this study was to determine the binding phenotype of
Plasmodium knowlesi infected human erythrocytes to recombinant human ICAM-1, VCAM and CD36.
Methods: Five patients with PCR-confirmed P. knowlesi malaria were recruited into the study with consent
between April and August 2010. Pre-treatment venous blood was washed and cultured ex vivo to increase the
proportion of schizont-infected erythrocytes. Cultured blood was seeded into Petri dishes with triplicate areas
coated with ICAM-1, VCAM and CD36. Following incubation at 37°C for one hour the dishes were washed and the
number of infected erythrocytes bound/mm2 to PBS control areas and to recombinant human ICAM-1 VCAM and
CD36 coated areas were recorded. Each assay was performed in duplicate. Assay performance was monitored with
the Plasmodium falciparum clone HB3.
Results: Blood samples were cultured ex vivo for up to 14.5 h (mean 11.3 ± 1.9 h) to increase the relative
proportion of mature trophozoite and schizont-infected red blood cells to at least 50% (mean 65.8 ± 17.51%).
Three (60%) isolates bound significantly to ICAM-1 and VCAM, one (20%) isolate bound to VCAM and none of the
five bound significantly to CD36.
Conclusions: Plasmodium knowlesi infected erythrocytes from human subjects bind in a specific but variable
manner to the inducible endothelial receptors ICAM-1 and VCAM. Binding to the constitutively-expressed
endothelial receptor CD36 was not detected. Further work will be required to define the pathological
consequences of these interactions.
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Background
Coma is one of the manifestations of Plasmodium falci-
parum malaria in children and adults [1,2] and it carries a
poor prognosis. The accumulation of cytoadherent parasi-
tized erythrocytes in post-capillary venules of the brain is
strongly causally implicated in precipitating malarial coma
[3-5]. Adherence to brain and other endothelial surfaces is
mediated by the expression of variant parasite-derived
proteins (Pf EMP1 var family) on the P. falciparum
infected erythrocyte surface [6]. PfEMP1 proteins predo-
minantly bind to CD36, but also to inducible Intercellular
Adhesion Molecule 1 (ICAM-1) [7-10]. Binding to up-
regulated ICAM-1 is particularly important in cytoadher-
ence to brain endothelium because CD36 is not expressed
in this endothelial compartment [8,9].
Malarial coma is rare in other infections by the human
host-adapted Plasmodium species and coma has not
been a feature of severe and fatal zoonotic Plasmodium
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knowlesi malaria [11-13]. However, post mortem exami-
nation of a fatal case of severe knowlesi malaria without
coma showed brain capillaries and venules congested
with infected erythrocytes [14]. Expressed parasite var-
iant surface antigens had been described in experimental
P. knowlesi infections of rhesus monkeys before PfEMP1
was identified in P. falciparum [15]. Plasmodium know-
lesi surface proteins were named Schizont-Infected Cell
Agglutination Antigens (SICA) and are encoded by the
SICAvar gene family [16]. Although distantly related,
SICAvar proteins share binding signature motifs with
PfEMP1 proteins [17]. The remarkable histological simi-
larity between brain sections from fatal P. knowlesi
malaria and fatal cases of severe falciparum malaria with
coma [14,18], particularly the accumulation of infected
erythrocytes in brain microvasculature, led to the design
of this study to test the binding characteristics of P.
knowlesi isolates from patients [9].
Methods
Patient recruitment
Patients with malaria admitted to Hospital Sarikei in
Sarawak, Malaysian Borneo were recruited, with
informed consent, into this study between April and
August 2010. The study was approved by the Malaysian
Ministry of Health Medical Research and Ethics Com-
mittee. Infecting species was confirmed by Plasmodium
species-specific nested-PCR assays [19] and only patients
with single species infections were retained in the study.
Blood collection and ex vivo parasite development
Approximately 2.5 mL of pre-treatment venous blood
from each patient was collected into EDTA. RPMI 1640
medium supplemented with 20 mM D-glucose, 25 mM
HEPES, 25 mg/ml gentamicin sulphate, 15% human AB
plasma with 0.2 mM hypoxanthine was used for parasite
culture. Gently washed loosely packed cells from each
patient were re-suspended in culture medium to
approximately 5% haematocrit and cultured at 37°C
under 5% O2, 5% CO2 and 90% N2. Thin blood film
microscopy was used to follow parasite development
until at least half the parasites had developed into late
trophozoites (parasites with dense cytoplasm and undi-
vided nuclear chromatin mass) and schizonts (at least
three divided nuclear chromatin masses with pigment
granules). See Figure 1a and 1b.
Static protein binding assays
A method adapted from McCormick et al. [9] to test
the ability of infected erythrocytes to bind to purified
recombinant human Fc chimera ICAM-1, VCAM, and
CD36 (R&D Systems, Minneapolis, USA) was used.
Three identical areas of each Petri dish (60 mm dia-
meter, product code 351007, Becton, Dickenson and
Company, NJ, USA) were treated with 2 μl aliquots of
purified ICAM-1, VCAM, CD36, each at 100 μg/mL.
Control areas were treated with phosphate buffered sal-
ine (PBS) and three marked areas were left untreated.
The dishes were incubated in a humid chamber at 37°C
for two hours before aspirating off excess protein and
blocking all areas with 1% w/v bovine serum albumin in
PBS for 2 h at 37°C. The blocking solution was removed
by gentle pipetting. Ex vivo matured infected erythrocyte
cultures were added to 3 ml warmed binding buffer
(RPMI 1640 media supplemented with D-glucose) to a
final haematocrit of 3%. Each protein and the PBS con-
trol were represented in triplicate per dish and duplicate
dishes were seeded per patient isolate. Therefore there
Ă ď Đ
Figure 1 Plasmodium knowlesi static binding assay. On admission to the study this patient had predominantly ring (immature trophozoite)
stage parasites (a). Following a period of in vitro culture the parasites matured, in this case to late trophozoite stages, as required for the static
binding assay (b). Infected erythrocytes bound to an ICAM-1 coated area of the assay dish are marked with arrows (c).
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were six replicate areas per protein or PBS control for
each patient sample assayed. Dishes were seeded with
1.5 ml of the prepared ex vivo cultured cell suspension
per patient isolate and a third assay dish with P. falci-
parum clone HB3 as an assay performance control.
The dishes were incubated at 37°C for 1 h, with gentle
mixing at 10 min intervals. Unbound cells were removed
by gentle washing seven times with RPMI 1640 supple-
mented with D-glucose. Bound cells were fixed with 1%
v/v gluteraldehyde for 1 h and stained with 10% Giemsa.
For example see Figure 1c. Using an inverted light
microscope at × 300 magnification images from ten
consecutive non-overlapping fields for each protein and
PBS treated area (six areas each per patient sample)
were captured. This was equivalent to an area of 0.135
mm2. The number of bound infected cells/0.135 mm2/
protein or control were counted. The results were
expressed as the number of infected cells (IE) bound/
mm2 to each of the proteins or control [IE/mm2 = (1/
0.0135) × mean number of bound IE per field]. Signifi-
cant binding of P. falciparum clone HB3 to all three test
proteins compared with PBS was required in the assay
performance control to validate the results for each
patient isolate. Purified protein binding assays on
primary field isolates are quantifiable within but not
between isolates because of variability in parasitaemia.
Significant binding to each protein compared with bind-
ing to PBS was determined using the Mann-Whitney U
Test (Graphpad PRISM version 4.0a San Diego Califor-
nia, USA).
Results
Five patients with PCR confirmed single species P.
knowlesi infections were recruited into the study. Parasi-
taemia ranged from 0.4 to 7%. Clinical and parasitologi-
cal data are summarised in Table 1. Apart from patient
(P0009) with high parasitaemia and renal failure the
patients had acute uncomplicated malaria. Blood sam-
ples were cultured ex vivo for up to 14.5 h (mean 11.3 ±
1.9 h) to allow parasite maturation and increase the
relative proportion of mature trophozoite and schizont-
infected red blood cells to at least 50% (mean 65.8 ±
17.51%) of all parasite stages present in preparation for
binding assays (Table 1).
Binding to ICAM-1, VCAM and CD36
Three (60%) isolates bound significantly to ICAM-1 and
VCAM. One (20%) isolate bound significantly to VCAM
Table 1 Patient demographic, clinical and laboratory features including ex vivo parasite development in preparation
for static binding assays
Patient details
Study reference P0002 P0006 P0009 P0010 P0011
Age 16 47 28 27 37
Sex M F M M M
% Parasitaemia 0.4 0.8 7 0.8 1.3
Fever duration (days) 7 5 6 5 4
Axillary Temp°C 37.5 38.5 39.2 38.7 38
Mean Art BP mmHg 79 96 70 86 77
Pulse per min 62 96 96 103 94
Haemoglobin g/dL 13.4 13.2 12.3 14.1 12.8
Platelets/uL 93,000 106,000 19,000 39,000 65,000
White cells/uL 6600 6700 6900 7500 4600
Sodium mmol/L 133 131 120 132 131
Potassium mmol/L 3.7 4.9 3.6 3.3 3.9
Chloride mmol/L 100 99 92 101 100
Total bilirubin umol/L 20.6 15.7 38.4 9.7 48.9
Conjugated bilirubin umol/L 5 12.8 23 4 32.6
Alkaline phosphatase U/L 100 62 87 131 233
Alanine aminotransferase U/L 28 21 43 35 68
Asparagine aminotransferase UL 17 30 118 23 22
Blood urea mmol/L 4.4 5.7 44.7 6 8.8
Serum creatinine umol/L - 78 600 59 133
Static binding assay details
% Mature Troph/Schizonts before ex vivo culture 25 40 17 10 10
Hours ex-vivo culture 10 14.5 10 10 12
% Mature Troph/Schizonts at start of assay 75 50 91 63 50
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and one isolate did not bind significantly to ICAM-1,
VCAM or CD36 (Figure 2). None of the P. knowlesi iso-
lates tested showed significant binding to CD36 (Figure
2). The performance of each binding assay was moni-
tored using P. falciparum clone HB3. Clone HB3 signifi-
cantly bound to ICAM-1, VCAM and CD36 in all assay
plates and clone HB3 binding characteristics are sum-
marised in Figure 2.
Discussion
Plasmodium knowlesi infected erythrocytes from human
infections bind in a specific but variable manner to the
human endothelial cell receptors ICAM-1 and VCAM
but not to CD36. Specific binding of infected erythro-
cytes to endothelial cell receptors is responsible for
cytoadherence and, therefore, sequestration of late tro-
phozoite and schizont infected erythrocytes from the
peripheral blood circulation in P. falciparum malaria [6].
With few exceptions only immature trophozoite stages
of P. falciparum infected erythrocytes are found in the
circulation of patients with acute uncomplicated falci-
parum malaria. Plasmodium falciparum PfEMP1 pro-
teins predominantly bind to CD36, a constitutively
expressed scavenger pattern recognition protein, and
variably to ICAM-1 and other up-regulated endothelial
cell receptors [8,9,20,21]. CD36 is not expressed on
areas of brain endothelium where cytoadherence occurs
[22] and binding to ICAM-1 on brain endothelium is
implicated in the pathophysiology of severe falciparum
malaria with coma [8,9,20]. Particular expression of
PfEMP1 variants, with differential ability to bind ICAM-
1, has been demonstrated in malaria patients with coma
[22,23]. Parasite sequestration through cytoadherence in
P. falciparum infections can be organ specific but it is
not clear yet whether this equates with virulence rather
than with available binding sites and parasite binding
affinity [20,21,24,25]. There is some data to suggest stra-
tification of the var type early in infection and it has
been suggested that cytoadherence to available receptors
is responsible for this [26]. Mature stage parasites are
observed in the circulation of all other types of malaria
of humans, including P. knowlesi malaria. However, this
does not exclude the possibility of a degree of parasite
sequestration by specific binding to endothelial cell
receptors or by other means. ICAM-1 is expressed in
low copy number in resting endothelium and is up-
regulated in inflammation and infection [25,27,28]
including severe malaria with coma [7]. In falciparum
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Figure 2 Infected red cell binding (IRBC) to purified ICAM-1, VCAM and CD36 compared with binding to intra assay PBS controls for
P. knowlesi infected patients P0002, P0006, P0009. P0010 and P0011. The median and inter quartile range (IQR) of six replicates per
protein or PBS control per isolated are shown. The performance character of the assay is represented by P. falciparum clone HB3 showing the
median (IQR) binding of all control assays (15 replicates per protein and PBS). Significance of binding was analaysed using the Mann-Whitney U
test comparing specific binding of IRBC/mm2 to each purified protein with intra assay binding to PBS control areas: * p = < 0.05; ** p = < 0.01;
***p = < 0.0001.
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malaria TNF has been implicated in ICAM-1 up-regula-
tion although infected red blood cells alone are suffi-
cient to produce this effect [25]. Plasmodium
falciparum isolates from patients with differing degrees
of disease severity show endothelial receptor binding
diversity [29] with binding to ICAM-1 highest and most
robust in P. falciparum isolates from patients with
severe malaria with coma [22,29]. Plasmodium knowlesi
proteins expressed on infected erythrocytes do not
appear to bind to CD36 is this study. This lack of adhe-
sion in a robust manner to constitutively expressed
abundant endothelial receptors, such as CD36, would
explain the presence of mature stage parasites in the cir-
culation when inducible target receptors are not up-
regulated. Significant but variable binding of P. knowlesi
infected erythrocytes from human infections to the
inducible endothelial receptors ICAM-1 and VCAM was
demonstrated here. This result suggests that, if up-regu-
lated on brain endothelium, P. knowlesi infected erythro-
cytes could potentially cytoadhere to ICAM-1 in that
compartment. Notwithstanding this possibility, immuno-
histochemistry failed to detect ICAM-1 on the endothe-
lial surfaces in parasite congested brain sections of a
fatal case of severe knowlesi malaria without coma [14].
There may be technical explanations for the failure to
detect ICAM-1 including limited available sections,
delayed post-mortem sampling and loss of tissue integ-
rity. It is also possible that ICAM-1 is not induced on
brain endothelium in knowlesi infections and that speci-
fic binding ex vivo is not associated with parasite viru-
lence in this species. The intense accumulation of
infected erythrocytes observed in brain sections in fatal
knowlesi malaria may have occurred through processes
other than specific cytoadherence, for example infected
cell agglutination [15]. This study and clinical descrip-
tions of severe and fatal knowlesi malaria suggest that
up-regulation of ICAM-1 observed in P. falciparum
infections is less evident in P. knowlesi malaria and that
direct or indirect induction of ICAM-1 may be a defin-
ing Plasmodium species-specific virulence factor in
severe malaria with coma.
Conclusions
In summary, P. knowlesi infected erythrocytes from
human subjects can bind to the inducible endothelial
receptors ICAM-1 and VCAM. Further work will be
required to define the pathological implication of these
interactions.
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